Abstract
We have devised a barcoding strategy to recapitulate cancer evolution through the emergence of subclonal mutations of interest, whose effects can be monitored in a dynamic manner. This approach can be easily adapted for a variety of applications, including combined modeling of multiple mechanisms of drug resistance or repair of oncogenic driver mutations in addicted cancer cells.
Original language | English |
---|---|
Article number | e1227894 |
Journal | Molecular and Cellular Oncology |
Volume | 3 |
Issue number | 6 |
DOIs |
|
State | Published - 1 Nov 2016 |
Keywords
- ALK
- APC
- CRISPR/Cas9
- EGFR
- TP53
- genetic barcoding
- non-small cell lung cancer
- resistance
- tumor heterogeneity